See more : Blackrock Silver Corp. (BRC.V) Income Statement Analysis – Financial Results
Complete financial analysis of Mind Cure Health Inc. (MCUR.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mind Cure Health Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Capital Partners S.A. (CPA.WA) Income Statement Analysis – Financial Results
- Alkermes plc (ALKS) Income Statement Analysis – Financial Results
- Cathay Consolidated, Inc. (1342.TW) Income Statement Analysis – Financial Results
- Hyfusin Group Holdings Limited (8512.HK) Income Statement Analysis – Financial Results
- LleidaNetworks Serveis Telemàtics, S.A. (LLN.MC) Income Statement Analysis – Financial Results
Mind Cure Health Inc. (MCUR.CN)
About Mind Cure Health Inc.
Mind Cure Health Inc., a life sciences company, develops and commercializes mental health and wellness products in North America. It focuses on the development of digital therapeutics technology and researching psychedelic compounds to rapidly scale science-backed and evidence-based mental health therapy. The company develops iSTRYM, a digital therapeutics tool and first-of-its-kind software application that optimizes the healing journey for patients and clinicians before, during, and after therapy sessions; PsyCollage, a bioinformatics platform that helps to drive research by identifying priority research programs; synthetic ibogaine to supply researchers and clinicians; and psychedelic compounds, including ibogaine for traumatic brain injuries and related conditions. Mind Cure Health Inc. was incorporated in 2020 and is headquartered in Vancouver, Canada.
| Metric | 2022 | 2021 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% |
| Research & Development | 48.25K | 50.36K |
| General & Administrative | 9.74M | 10.21M |
| Selling & Marketing | 262.69K | 204.55K |
| SG&A | 10.00M | 10.41M |
| Other Expenses | 9.75K | 0.00 |
| Operating Expenses | 10.06M | 10.46M |
| Cost & Expenses | 10.06M | 10.46M |
| Interest Income | 94.41K | 33.25K |
| Interest Expense | 87.69K | 0.00 |
| Depreciation & Amortization | 9.75K | 236.56K |
| EBITDA | -5.88M | -10.73M |
| EBITDA Ratio | 0.00% | 0.00% |
| Operating Income | -5.89M | -10.73M |
| Operating Income Ratio | 0.00% | 0.00% |
| Total Other Income/Expenses | -8.25M | 789.04K |
| Income Before Tax | -14.14M | -10.17M |
| Income Before Tax Ratio | 0.00% | 0.00% |
| Income Tax Expense | 8.16M | -290.65K |
| Net Income | -22.30M | -9.88M |
| Net Income Ratio | 0.00% | 0.00% |
| EPS | -0.24 | -0.17 |
| EPS Diluted | -0.24 | -0.17 |
| Weighted Avg Shares Out | 93.85M | 57.31M |
| Weighted Avg Shares Out (Dil) | 93.85M | 57.31M |
Source: https://incomestatements.info
Category: Stock Reports